“Cold, common”的搜索结果，显示 911-920 项，共有 10970 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Does the treatment show effectiveness on advanced sarcoma. Participants will: Take drug [Ac225]RTX-2358 once every 8 weeks (4 cycle target; 6 cycle maximum) ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

3. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the ...

7. 冻伤 - 症状与病因- 妙佑医疗国际

   com/professional/injuries-poisoning/cold-injury/frostbite. Accessed July 16, 2020. Madden C. Exercise in the cold and cold injuries. In: Netter's Sports ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. Accordingly, data evaluating the potential differences in ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...